Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Current Leases (2019 - 2025)

Vycor Medical has reported Current Leases over the past 7 years, most recently at $52221.0 for Q4 2025.

  • Quarterly Current Leases rose 8.44% to $52221.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52221.0 through Dec 2025, up 8.44% year-over-year, with the annual reading at $52221.0 for FY2025, 8.44% up from the prior year.
  • Current Leases was $52221.0 for Q4 2025 at Vycor Medical, up from $51179.0 in the prior quarter.
  • Over five years, Current Leases peaked at $52221.0 in Q4 2025 and troughed at $4280.0 in Q2 2023.
  • The 5-year median for Current Leases is $46395.0 (2021), against an average of $42789.0.
  • Year-over-year, Current Leases tumbled 91.11% in 2023 and then surged 985.65% in 2024.
  • A 5-year view of Current Leases shows it stood at $46915.0 in 2021, then plummeted by 36.93% to $29591.0 in 2022, then surged by 53.16% to $45321.0 in 2023, then grew by 6.26% to $48158.0 in 2024, then grew by 8.44% to $52221.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Current Leases are $52221.0 (Q4 2025), $51179.0 (Q3 2025), and $50157.0 (Q2 2025).